Skip to Content
PETNET Solutions, a fully owned subsidiary of Siemens Medical solutions, operates the largest PET radiopharmacy network with over 44 radiopharmacies and distribution centers at multiple locations that produce and distribute PET radiopharmaceuticals to hospitals, clinics, and research facilities for PET imaging. The new facility in Chennai will produce and supply the required radiopharmaceuticals to the hospitals that have PET.CT (Positron Emission Tomography. Computed Tomography) facilities, which will ease the burden of healthcare providers to produce their own radiopharmaceuticals. As a result, it will also help in bringing down the cost of nuclear medicine and expand its reach to a wider community. The new facility will house the Siemens Eclipse HP cyclotron which will be deployed to manufacture FDG (fluorodeoxyglucose), the imaging biomarker used in PET.CT facilities to assist with the diagnosis and staging of disease processes and to monitor cellular response to treatments such as chemotherapy and radiotherapy.
Currently, there is no PET.CT in Tamil Nadu because of non availability the vital imaging biomarker FDG, which is essential to do the imaging in PET.CT. FDG has a half-life of only 110 minutes (losing half of its activity every 110 minutes) and hence needs to be produced locally. The new cyclotron will guarantee reliable delivery of PET radiopharmaceutical and will vastly increase availability of FDG, which means that many more patients in Chennai and in other locations within transporting distance will have access to world-class PET.CT imaging. For cancer patients, this will allow for earlier lesion detection and differential diagnosis of primary cancers, which is important for treatment and disease management.
Speaking on this initiative, Mr. Ragavan, Head-Siemens Medical Solutions-India said “In India, over a million people are diagnosed with cancer every year and there is a growing need among the healthcare providers to access the latest technology in fighting this life-threatening disease. PET.CTs help doctors to detect cancer early and comprehensively and help them and even patients to check if the treatment applied has been successful. World over, PET.CTs are helping doctors to understand the stage and progress of cancer and accordingly treat it more holistically. The local availability of FDG is very critical for healthcare providers, to put the PET.CT technology to the benefit of the patients, and therefore we are very proud to establish this facility which will fill a critical gap in the Healthcare Infrastructure of Tamil Nadu. Apart from Chennai, we are also considering expansion of this network to other parts of the country.”
About PETNET Solutions
PETNET Solutions is a fully owned subsidiary of Siemens Medical solutions. Founded in 1996 with 12 radiopharmacies, PETNET Solutions envisioned growing its network of radiopharmacies to promote global PET utilization. As molecular imaging evolves, PETNET Solutions delivers products and services that expand the value of PET to providers, referring physicians and patients. PETNET Solutions is delivering, expanding, and advancing the science of PET. Its solutions deliver high quality PET tracers. Every dose distributed by PETNET Solutions is guaranteed to meet the United States Pharmacopoeia Standards for product quality and purity from production to labeled expiration time.
About Siemens Medical Solutions
Siemens Medical Solutions is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Medical Solutions will be the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. The company delivers solutions across the entire continuum of care -- from prevention and early detection, to diagnosis, therapy and care. Siemens Medical Solutions employs more than 48,000 people worldwide and operates in 130 countries. According to U.S. GAAP, in the fiscal year 2007 (Sept. 30), Siemens Medical Solutions reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion (preliminary figures, unaudited). Further information can be found by visiting http://www.siemens.com/medical.
About Siemens Ltd
Siemens Ltd is the flagship listed company in India. Siemens in India, which comprises of 19 legal entities, is a leading provider of industry and infrastructure solutions with a business volume aggregating about Rs 11,000 crores. It operates in the core business segments of Energy, Industry Transportation, Healthcare, Information Technology, Communication and Lighting. It has nation-wide Sales and Service network, 18 manufacturing plants, some 500 strong network of channel partners and employs over 18,000 people.